Clinical and biological implications of driver mutations in myelodysplastic syndromes
Top Cited Papers
Open Access
- 21 November 2013
- journal article
- Published by American Society of Hematology in Blood
- Vol. 122 (22), 3616-3627
- https://doi.org/10.1182/blood-2013-08-518886
Abstract
Key Points. MDS is characterized by mutations in >40 genes, a complex structure of gene-gene interactions and extensive subclonal diversification.The totalKeywords
This publication has 49 references indexed in Scilit:
- Clonal diversity of recurrently mutated genes in myelodysplastic syndromesLeukemia, 2013
- Recurrent SETBP1 mutations in atypical chronic myeloid leukemiaNature Genetics, 2012
- The Origin and Evolution of Mutations in Acute Myeloid LeukemiaCell, 2012
- The landscape of cancer genes and mutational processes in breast cancerNature, 2012
- The Life History of 21 Breast CancersCell, 2012
- Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencingNature, 2012
- Recurrent mutations in the U2AF1 splicing factor in myelodysplastic syndromesNature Genetics, 2011
- Recurrent DNMT3A mutations in patients with myelodysplastic syndromesLeukemia, 2011
- Genome remodelling in a basal-like breast cancer metastasis and xenograftNature, 2010
- The cancer genomeNature, 2009